Frequency of hot flushes Oral beta‐estradiol 1.0 and 2.0 mg/day vs CEE 0.625 or 1.25 mg/day · women with hot flushes
1 finding from 1 review
Adverse events Oral beta‐estradiol 1.0 or 2.0 mg/day vs CEE 0.625 or 1.25 mg/day · women with hot flushes
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
Oral beta‐estradiol showed no clear difference in frequency of hot flushes Oral beta‐estradiol 0.5‐1.0 mg/day compared with placebo (low certainty).
1 finding from 1 review
Adverse effects Oral beta‐estradiol 0.5‐2.0 mg/day · women with hot flushes
1 finding from 1 review
Time (days) spent in NICU ‐ not reported · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · preterm infants
1 finding from 1 review
Duration (days) of parenteral nutrition · preterm infants
1 finding from 1 review
Postoperative ileus · Women who had major abdominal gynaecologic surgery
Early oral feeding showed no clear difference in postoperative ileus compared with delayed oral feeding (moderate certainty).
1 finding from 1 review
Maternal nausea and/or vomiting · Women who had major abdominal gynaecologic surgery
Early oral feeding showed no clear difference in nausea or vomiting or both compared with delayed oral feeding (moderate certainty).
1 finding from 1 review
Time to bowel sounds [days] · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Time from completion of operation to first flatus (hours) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Postoperative time to solid diets (days) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Time to first BM (№ women with 1st BM on day 2 after delivery) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Length of hospital stay · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening · children undergoing neurodiagnostic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent · children undergoing neurodiagnostic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) · children undergoing neurodiagnostic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who had sedation failure or inadequate level of sedation · children undergoing neurodiagnostic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
EEG sedative‐induced artefact · children undergoing neurodiagnostic procedures
Chloral hydrate oral (50 mg/kg) may leads to lower EEG sedative‐induced artefact compared with melatonin oral (low certainty).
1 finding from 1 review
Number of children with clinical adverse events (any) · children undergoing neurodiagnostic procedures
Chloral hydrate oral (50 mg/kg) showed no clear difference in number of children with clinical adverse events (any) compared with melatonin oral (low certainty).
1 finding from 1 review